NCT06722183
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06722183
Title A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities (FUTURE)
Acronym FUTURE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Klinikum St. Marien Amberg NOT_YET_RECRUITING Amberg Germany Details
Charité Campus Virchow Klinikum (CVK) NOT_YET_RECRUITING Berlin Germany Details
Universitätsklinikum Düsseldorf RECRUITING Düsseldorf Germany Details
Kliniken Essen-Mitte RECRUITING Essen Germany Details
Krankenhaus Nordwest RECRUITING Frankfurt am Main 60488 Germany Details
Hope Hamburg RECRUITING Hamburg Germany Details
Universitätsmedizin Mainz NOT_YET_RECRUITING Mainz Germany Details
Klinikum München rechts der Isar RECRUITING München Germany Details
MVZ für Hämatologie und Onkologie Ravensburg GmbH NOT_YET_RECRUITING Ravensburg 88212 Germany Details
Leopoldina Krankenhaus Schweinfurt RECRUITING Schweinfurt Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field